Nyxoah (NYXH) Competitors $8.18 +0.21 (+2.57%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NYXH vs. LQDA, SSII, PLSE, INMD, MDXG, KMTS, SIBN, IRMD, CBLL, and EMBCShould you be buying Nyxoah stock or one of its competitors? The main competitors of Nyxoah include Liquidia Technologies (LQDA), SS Innovations International (SSII), Pulse Biosciences (PLSE), InMode (INMD), MiMedx Group (MDXG), Kestra Medical Technologies (KMTS), SiBone (SIBN), iRadimed (IRMD), CeriBell (CBLL), and Embecta (EMBC). These companies are all part of the "medical equipment" industry. Nyxoah vs. Its Competitors Liquidia Technologies SS Innovations International Pulse Biosciences InMode MiMedx Group Kestra Medical Technologies SiBone iRadimed CeriBell Embecta Liquidia Technologies (NASDAQ:LQDA) and Nyxoah (NASDAQ:NYXH) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, risk, profitability, institutional ownership and media sentiment. Which has more risk & volatility, LQDA or NYXH? Liquidia Technologies has a beta of -0.01, meaning that its stock price is 101% less volatile than the S&P 500. Comparatively, Nyxoah has a beta of 1.62, meaning that its stock price is 62% more volatile than the S&P 500. Is LQDA or NYXH more profitable? Liquidia Technologies has a net margin of -903.80% compared to Nyxoah's net margin of -1,571.39%. Nyxoah's return on equity of -63.37% beat Liquidia Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Liquidia Technologies-903.80% -177.91% -60.15% Nyxoah -1,571.39%-63.37%-46.67% Which has preferable valuation & earnings, LQDA or NYXH? Nyxoah has lower revenue, but higher earnings than Liquidia Technologies. Liquidia Technologies is trading at a lower price-to-earnings ratio than Nyxoah, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLiquidia Technologies$14M89.15-$130.39M-$1.58-9.24Nyxoah$4.36M64.62-$64.10M-$2.13-3.89 Do analysts prefer LQDA or NYXH? Liquidia Technologies currently has a consensus target price of $26.89, indicating a potential upside of 84.17%. Nyxoah has a consensus target price of $14.50, indicating a potential upside of 75.12%. Given Liquidia Technologies' higher probable upside, equities analysts plainly believe Liquidia Technologies is more favorable than Nyxoah.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Liquidia Technologies 1 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.00Nyxoah 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media favor LQDA or NYXH? In the previous week, Liquidia Technologies had 20 more articles in the media than Nyxoah. MarketBeat recorded 20 mentions for Liquidia Technologies and 0 mentions for Nyxoah. Nyxoah's average media sentiment score of 1.89 beat Liquidia Technologies' score of 0.25 indicating that Nyxoah is being referred to more favorably in the news media. Company Overall Sentiment Liquidia Technologies Neutral Nyxoah Very Positive Do institutionals and insiders hold more shares of LQDA or NYXH? 64.5% of Liquidia Technologies shares are owned by institutional investors. 26.5% of Liquidia Technologies shares are owned by insiders. Comparatively, 17.1% of Nyxoah shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. SummaryLiquidia Technologies beats Nyxoah on 10 of the 16 factors compared between the two stocks. Get Nyxoah News Delivered to You Automatically Sign up to receive the latest news and ratings for NYXH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NYXH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NYXH vs. The Competition Export to ExcelMetricNyxoahMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$282.02M$1.97B$5.50B$9.39BDividend YieldN/AN/A4.25%4.09%P/E Ratio-3.8934.3528.1019.86Price / Sales64.6211.47402.2879.25Price / CashN/A53.6035.5357.53Price / Book2.308.678.265.72Net Income-$64.10M-$62.39M$3.24B$257.80M7 Day Performance6.98%-0.78%0.50%1.06%1 Month Performance6.98%13.29%7.99%11.30%1 Year Performance-10.00%6.02%28.68%17.00% Nyxoah Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NYXHNyxoah2.5397 of 5 stars$8.28+3.9%$14.50+75.1%-15.2%$282.02M$4.36M-3.89110Positive NewsLQDALiquidia Technologies3.2305 of 5 stars$12.45+2.1%$26.89+116.0%+10.6%$1.04B$14M-7.8850Insider TradeSSIISS Innovations InternationalN/A$5.27-1.3%N/AN/A$1.03B$20.65M0.004PLSEPulse Biosciences3.7595 of 5 stars$15.81+3.3%$22.00+39.2%-18.5%$1.03B$700K0.00140INMDInMode4.0997 of 5 stars$15.10-0.4%$18.54+22.8%-25.2%$958.25M$394.82M6.48480News CoveragePositive NewsMDXGMiMedx Group3.7173 of 5 stars$6.48+2.2%$12.50+92.9%-10.3%$936.43M$348.88M24.00870News CoverageAnalyst ForecastKMTSKestra Medical TechnologiesN/A$14.75-5.9%$27.50+86.4%N/A$804.64M$52.64M0.00300News CoverageAnalyst ForecastSIBNSiBone3.89 of 5 stars$18.01-2.5%$22.50+24.9%+0.8%$787.09M$167.18M-28.14350Positive NewsIRMDiRadimed4.9236 of 5 stars$59.02-4.5%$72.00+22.0%+23.7%$785.79M$73.24M38.08110Positive NewsCBLLCeriBell2.662 of 5 stars$17.20-9.1%$32.14+86.9%N/A$684.19M$65.44M0.00N/AEMBCEmbecta4.6848 of 5 stars$10.03-2.8%$19.33+92.8%-26.1%$603.13M$1.08B11.142,100Analyst Forecast Related Companies and Tools Related Companies Liquidia Technologies Competitors SS Innovations International Competitors Pulse Biosciences Competitors InMode Competitors MiMedx Group Competitors Kestra Medical Technologies Competitors SiBone Competitors iRadimed Competitors CeriBell Competitors Embecta Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NYXH) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nyxoah SA Please log in to your account or sign up in order to add this asset to your watchlist. Share Nyxoah With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
